I-FACTOR PEPTIDE ENHANCED BONE GRAFT

Filler, Bone Void, Synthetic Peptide

FDA Premarket Approval P140019

This medical device has supplements. The device description/function or indication may have changed. Be sure to look at the supplements to get an up-to-date information on device changes. The labeling included below is the version at time of approval of the original pma or panel track supplement and may not represent the most recent labeling.

Pre-market Approval Supplement Details

Approval for the i-factor peptide enhanced bone graft. This combination product is indicated for use in skeletally mature patients for reconstruction of a degenerated cervical disc at one level from c3-c4 to c6-c7 following single-level discectomy for intractable radiculopathy (arm pain and/or a neurological deficit), with or without neck pain, or myelopathy due to a single-level abnormality localized to the disc space, and corresponding to at least one of the following conditions confirmed by radiographic imaging (ct, mri, x-rays): herniated nucleus pulposus, spondylosis (defined by the presence of osteophytes), and/or visible loss of disc height as compared to adjacent levels, after failure of at least 6 weeks of conservative treatment. I-factor peptide enhanced bone graft p-15 putty must be used inside an allograft bone ring and with supplemental anterior plate fixation.

DeviceI-FACTOR PEPTIDE ENHANCED BONE GRAFT
Classification NameFiller, Bone Void, Synthetic Peptide
Generic NameFiller, Bone Void, Synthetic Peptide
ApplicantCERAPEDICS, LLC
Date Received2014-08-27
Decision Date2015-11-03
Notice Date2015-11-30
PMAP140019
SupplementS
Product CodeNOX
Docket Number15M-4343
Advisory CommitteeOrthopedic
Expedited ReviewNo
Combination Product Yes
Applicant Address CERAPEDICS, LLC 11025 Dover Street suite 1600 westminster, CO 80021
Summary:Summary of Safety and Effectiveness
Labeling: Labeling Labeling Part 2
Post-Approval Study:Show Report Schedule and Study Progress
Approval Order: Approval Order

Supplemental Filings

Supplement NumberDateSupplement Type
P140019Original Filing
S007 2022-10-19 30-day Notice
S006 2022-01-19 30-day Notice
S005 2021-12-09 30-day Notice
S004 2020-06-15 Normal 180 Day Track No User Fee
S003 2019-04-17 Normal 180 Day Track No User Fee
S002 2016-01-19 Normal 180 Day Track
S001 2015-12-03 Normal 180 Day Track No User Fee

NIH GUDID Devices

Device IDPMASupp
00850001680028 P140019 000
M8517000101 P140019 002
00850001680011 P140019 002
00850001680004 P140019 002

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.